Previous Close | 15.74 |
Open | 15.75 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 14.79 - 15.79 |
52 Week Range | 14.02 - 57.90 |
Volume | |
Avg. Volume | 1,840,220 |
Market Cap | 1.69B |
Beta (5Y Monthly) | 1.85 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.03 |
Earnings Date | Oct 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 24.71 |
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended to democratize access to single cell analysis. The new offerings – GEM-X Flex and GEM-X Universal Multiplex – introduce significant improvements in performance, workflow and cost effectiveness, enabling more researchers to pursue single cell analysis for more applications.
Tesla stock edges higher ahead of the electric-vehicle maker’s highly anticipated Robotaxi Day, while Delta shares fall after the carrier’s earnings miss analysts’ forecasts.